David M. Goldenberg
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.01%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 334
- Monoclonal and Polyclonal Antibodies Research 295
- Oncology 202
- HER2/EGFR in Cancer Research 71
- Peptidase Inhibition and Analysis 34
- Co-authors
- Robert M. Sharkey (241 shared papers)Chien‐Hsing Chang (103 shared papers)Hans J. Hansen (73 shared papers)Edmund A. Rossi (76 shared papers)Thomas M. Cardillo (76 shared papers)William J. McBride (67 shared papers)Rhona Stein (65 shared papers)Serengulam V. Govindan (69 shared papers)
- Journals
- Journal of Clinical Oncology (58 papers)Blood (56 papers)Cancer (44 papers)Cancer Research (36 papers)International Journal of Cancer (32 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
David M. Goldenberg
738 papers receiving 27.5k citations
David M. Goldenberg's Hit Papers
Peers
Comparison fields: 5 of 185
- Radiology, Nuclear Medicine and Imaging 14.8k
- Oncology 9.2k
- Pathology and Forensic Medicine 3.3k
- Immunology 3.8k
- Genetics 1.5k
Countries citing papers authored by David M. Goldenberg
This map shows the geographic impact of David M. Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Goldenberg more than expected).
Fields of papers citing papers by David M. Goldenberg
This network shows the impact of papers produced by David M. Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Goldenberg. The network helps show where David M. Goldenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Goldenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 744 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer Hit paper breakdown → | 2019 | 624 |
| 2 | Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning Hit paper breakdown → | 1978 | 543 |
| 3 | A Review of Tissue Substitutes for Ultrasound Imaging Hit paper breakdown → | 2010 | 509 |
| 4 | Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)* Hit paper breakdown → | 2015 | 363 |
| 5 | 2009 | 327 | |
| 6 | 2005 | 268 | |
| 7 | 2015 | 261 | |
| 8 | Targeted therapy of cancer with radiolabeled antibodies. | 2002 | 249 |
| 9 | 2006 | 242 | |
| 10 | 1998 | 231 | |
| 11 | 2011 | 227 | |
| 12 | 2018 | 220 | |
| 13 | 2015 | 217 | |
| 14 | 2007 | 199 | |
| 15 | 2017 | 193 | |
| 16 | 1976 | 193 | |
| 17 | 2003 | 192 | |
| 18 | 2006 | 191 | |
| 19 | 2010 | 187 | |
| 20 | 2004 | 184 |
About David M. Goldenberg
David M. Goldenberg is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Pathology and Forensic Medicine and Immunology, having authored 744 papers that have together received 28.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (334 papers), Monoclonal and Polyclonal Antibodies Research (295 papers), Lymphoma Diagnosis and Treatment (107 papers), HER2/EGFR in Cancer Research (71 papers), Glycosylation and Glycoproteins Research (49 papers), Medical Imaging and Pathology Studies (35 papers), Peptidase Inhibition and Analysis (34 papers) and Neuroendocrine Tumor Research Advances (31 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (14.8k citations), Oncology (9.2k citations), Pathology and Forensic Medicine (3.3k citations), Immunology (3.8k citations) and Genetics (1.5k citations). David M. Goldenberg has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Robert M. Sharkey, Chien‐Hsing Chang, Hans J. Hansen, Edmund A. Rossi, Thomas M. Cardillo, William J. McBride, Rhona Stein, Serengulam V. Govindan, Rosalyn D. Blumenthal and William A. Wegener. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.